A carregar...

Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111

BACKGROUND AND PURPOSE: Nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor antagonists have been proposed as a novel therapeutic approach to Parkinson's disease. Main limitations of previous studies were the use of structurally similar compounds and the evaluation of their acute effects only...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Marti, M, Mela, F, Budri, M, Volta, M, Malfacini, D, Molinari, S, Zaveri, NT, Ronzoni, S, Petrillo, P, Calò, G, Morari, M
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3631376/
https://ncbi.nlm.nih.gov/pubmed/22994368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2012.02219.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!